Assessment of Fecal Calprotectin level in Inflammatory, Infectious and Malignant Gastrointestinal Diseases
Mahmoud, H., Fayed, H., El Dosoky, M., Tag-Adeen, M. (2021). Assessment of Fecal Calprotectin level in Inflammatory, Infectious and Malignant Gastrointestinal Diseases. EKB Journal Management System, 4(2), 14-24. doi: 10.21608/svuijm.2020.49745.1044
Hasan Sedeek Mahmoud; Hanan Mahmoud Fayed; Mahmoud El Dosoky; Mohammed Tag-Adeen. "Assessment of Fecal Calprotectin level in Inflammatory, Infectious and Malignant Gastrointestinal Diseases". EKB Journal Management System, 4, 2, 2021, 14-24. doi: 10.21608/svuijm.2020.49745.1044
Mahmoud, H., Fayed, H., El Dosoky, M., Tag-Adeen, M. (2021). 'Assessment of Fecal Calprotectin level in Inflammatory, Infectious and Malignant Gastrointestinal Diseases', EKB Journal Management System, 4(2), pp. 14-24. doi: 10.21608/svuijm.2020.49745.1044
Mahmoud, H., Fayed, H., El Dosoky, M., Tag-Adeen, M. Assessment of Fecal Calprotectin level in Inflammatory, Infectious and Malignant Gastrointestinal Diseases. EKB Journal Management System, 2021; 4(2): 14-24. doi: 10.21608/svuijm.2020.49745.1044

Assessment of Fecal Calprotectin level in Inflammatory, Infectious and Malignant Gastrointestinal Diseases

SVU-International Journal of Medical Sciences
Article 3, Volume 4, Issue 2, August 2021, Page 14-24  XML PDF (483.29 K)
Document Type: Original research articles
DOI: 10.21608/svuijm.2020.49745.1044
View on SCiNiTO View on SCiNiTO
Authors
Hasan Sedeek Mahmoud email orcid 1; Hanan Mahmoud Fayedorcid 2; Mahmoud El Dosoky3; Mohammed Tag-Adeen4
1Associate Professor , Tropical Medicine and Gastroenterology Department, Faculty of Medcine, South Valley University, Qena, Egypt
2Professor, Chemical and Clinical Pathology, Faculty of Medicine, South Valley University,Qena, Egypt
3Teaching Assistant , Pathology Department,Faculty of Medicine, South Valley University, Qena, Egypt
4Associate professor , Internal Medicine Department, Faculty of Medicine, South Valley University, Qena, Egypt
Abstract
Background:  Calprotectin is a marker of inflammation as it is a cytosolic protein in the neutrophilic granulocytes.
Objectives: We aimedto assess fecal calprotectin (FC) in the inflammatory, infectious and malignant gastrointestinal (G.I.T) diseases.
Patients and Methods: 169 patients presented with G.I.T symptoms and proved with inflammatory, infectious or malignant condition by histopathological examination of the G.I.T endoscopic specimens were recruited. Symptomatic subjects with normal findings were considered as a non-organic; comparable group. Complete blood count, E.S.R, C.R.P, liver function tests, kidney function tests and stool analysis followed by endoscopic examination and multiple biopsies were taken for histopathological examination. FC was measured for all subjects.  
Results: Out of 169 patients; 79 patients (53.7%) showed inflammatory/infectious lesions (34 of them were inflammatory bowel disease (I.B.D)), 68 (46.3%) were malignant lesions and, 22 of them showed non-organic lesions (13%). FC levels (median, IQR; interquartile range) were significantly higher in inflammatory, infection group and malignant group than in the non-organic group (145 (53-2467) and 136 (45-212) versus 17 (10-57) respectively, P value =0.000). Patients with I.B.D showed significantly higher values for FC than in those with non I.B.D, P value= 0.000. Colorectal cancer patients showed higher FC values than gastric or esophageal cancer, P value= 0.000.
Conclusions: FC is a useful marker in the diagnosis of G.I.T inflammatory, infectious and malignant conditions especially in I.B.D and colorectal cancer.
Keywords
Fecal calprotectin; Inflammatory; Infectious; Malignant; Gastrointestinal tract
Statistics
Article View: 769
PDF Download: 1,683